Why Is NEOGENOMICS INC (NEO) Stock Up Today?

NEO stock surged 16.04% to $15.55 in early trading on July 29, 2026, driven by a combination of strong Q2 2026 earnings results and revised guidance from the company. The stock opened with a 11.9% gap up from the previous close and reached a session high of $16.10 before settling near $15.53. The move followed a series of analyst upgrades and updated financial projections that signaled improved performance in clinical and next-generation sequencing (NGS) segments.

What Happened

On July 28, NeoGenomics filed a Form 8-K disclosing preliminary results for the second quarter of 2026. The company reported non-GAAP earnings per share of $0.05, exceeding estimates by $0.02, and revenue of $202 million, which beat estimates by $5.01 million. The firm also raised its full-year 2026 revenue guidance from $797 million to $803 million to $802 million to $806 million. The company attributed the strong performance to growth in clinical and NGS services, though it noted weaker performance in nonclinical pharma segments. Needham upgraded the stock with a higher price target of $19, citing the results. Benchmark also raised its price target to $16 and maintained a Buy rating.

What The Data Shows

The stock opened at $15.00, a $1.60 gap up from the prior close, and traded with a narrow range throughout the session. Volume of 0.3 million shares was below the 3-month average by 90%. The stock is currently trading near its 52-week high of $15.57 and has a market capitalization of $1.7 billion. Despite the recent revenue growth of 10.9% trailing twelve months, the company remains unprofitable with a net margin of -13.3% and an EPS TTM of -0.77. The stock’s beta of 1.74 suggests it is more volatile than the broader market.

What To Watch

The company’s updated guidance and analyst upgrades indicate continued focus on clinical and NGS growth. Investors should monitor the company’s progress in pharma services and any further guidance adjustments. No earnings date is provided, but coverage breadth remains strong with eight stories from four sources in the last 36 hours.